Cite

HARVARD Citation

    Zhong, C. et al. (2020). Efficacy of the novel tubulin polymerization inhibitor PTC‐028 for myelodysplastic syndrome. Cancer science. 111 (12), pp. 4336-4347. [Online]. 
  
Back to record